This inventor holds 1 USPTO granted patent. Top assignee: The University of Texas System. Active years: 1995.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1995
Title: Ralph S. Freedman: Innovator in Monoclonal Antibodies
Introduction
Ralph S. Freedman is a notable inventor based in Houston, Texas. He has made significant contributions to the field of biomedical research, particularly in the development of tumor-specific, cell surface-binding monoclonal antibodies. His work has the potential to advance cancer treatment and diagnostics.
Latest Patents
Ralph S. Freedman holds a patent for tumor-specific, cell surface-binding monoclonal antibodies. This innovation represents a crucial step in targeted cancer therapies, aiming to improve the efficacy of treatments while minimizing side effects.
Career Highlights
Freedman is affiliated with the University of Texas System, where he continues to engage in groundbreaking research. His career is marked by a commitment to advancing medical science and improving patient outcomes through innovative solutions.
Collaborations
Throughout his career, Freedman has collaborated with esteemed colleagues, including Constantin G. Ioannides and Barbara J. Tomasovic. These partnerships have fostered a collaborative environment that enhances research and development efforts.
Conclusion
Ralph S. Freedman is a distinguished inventor whose work in monoclonal antibodies is paving the way for advancements in cancer treatment. His contributions to the field are invaluable and continue to inspire future innovations.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile